Counseling is key to safe and effective opioid use and storage.
Opioid abusers are increasingly supplementing their habit with heroin.
Researchers examined the extent to which pharmaceutical industry marketing of opioid products to physicians during 2014 correlated with opioid prescribing in 2015.
Lofexidine may effectively mitigate the symptoms of opioid withdrawal in patients on long-term opioid therapy for chronic pain.
The increased opioid use has been associated with a rising incidence of opioid-induced endocrinopathy, most commonly in the form of androgen deficiency.
A motivational interviewing intervention delivered by trained counselors reduced the rate of opioid overdoses in participants with opioid use disorder.
A physician's baseline opioid prescribing rate was a strong predictor of a patient's future opioid use.
Nalbuphine can relieve opioid-induced urine retention.
Lofexidine may effectively alleviate opioid withdrawal symptoms.
One more step to combat the epidemic of opioid abuse.